Investtechs modelporteføljer steg i fjerde kvartal gennemsnitligt 10.6 procentpoint i forhold til referenceindeks. Især porteføljerne i Norge, Danmark og USA viste gode resultater, med merafkast på henholdsvis 27.5, 17.2 og 12.4 procentpoint.
Marked | Merafk. Q1* | Merafk. Q2* | Merafk. Q3* | Merafk. Q4* | Merafk. 2004 |
Stockholm | +3.7% | -0.5% | -5.2% | +4.3% | +2.3% |
Helsingfors | +3.9% | +11.8% | +7.2% | +2.3% | +25.2% |
Amsterdam | +13.0% | +7.3% | +5.7% | +11.1% | +37.1% |
København | +13.5% | +5.1% | -2.6% | +17.2% | +33.2% |
Oslo | -6.1% | -4.7% | -9.6% | +27.5% | +7.1% |
London | +3.8% | -3.4% | -3.6% | +3.2% | +0.0% |
Frankfurt/CDAX | +15.6% | -0.5% | -6.1% | +7.0% | +16.0% |
Nasdaq | -2.7% | +14.5% | -2.9% | +12.4% | +21.3% |
Snit | +5.59% | +3.70% | -2.1% | +10.6% | +17.8% |
For året 2004 er resultaterne gode, med afkast i gennemsnit 17.8 procentpoint bedre end referanceindeks.
Strategien fra tidligere anses fortsat god:
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.